Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Helena Yu, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc Davis Cancer Center (data Collection Only)
Sacramento, California, United States
Recruiting - University of California San Francisco
San Francisco, California, United States
Active, not recruiting - Moffitt Cancer Center
Tampa, Florida, United States
Recruiting - John Hopkins Medical Center
Baltimore, Maryland, United States
Recruiting - Massachusetts General Hospital (data Collection Only)
Boston, Massachusetts, United States
Recruiting - Memorial Sloan Kettering Basking Ridge (limited Protocol Activities)
Basking Ridge, New Jersey, United States
Recruiting - Hackensack Meridian Health
Hackensack, New Jersey, United States
Recruiting - Memorial Sloan Kettering Monmouth (limited Protocol Activities)
Middletown, New Jersey, United States
Recruiting - Memorial Sloan Kettering Bergen (limited Protocol Activities)
Montvale, New Jersey, United States
Recruiting - Memorial Sloan Kettering Commack (limited Protocol Activities)
Commack, New York, United States
Recruiting - Memorial Sloan Kettering Westchester (limited Protocol Activities)
Harrison, New York, United States
Recruiting - Columbia University (data Collection Only)
New York, New York, United States
Active, not recruiting - Memorial Sloan Kettering Cancer Center (all Protocol Activities)
New York, New York, United States
Helena Yu, MDRecruiting - New York University
New York, New York, United States
Recruiting - Memorial Sloan Kettering Nassau (limited Protocol Activities)
Uniondale, New York, United States
Recruiting - Sarah Cannon Research Institute
Nashville, Tennessee, United States
Recruiting - Md Anderson Cancer Center (data Collection Only)
Houston, Texas, United States
Recruiting - University of Washington (data Collection Only)
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 May 2020
- Primary completion
- 31 May 2027
- Completion
- 31 May 2027
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 571
- Registry id
- NCT04410796
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.